GLA-SE
IDC-G100-2013-001
Phase 1 mab completed
Quick answer
GLA-SE for Merkel Cell Carcinoma is a Phase 1 program (mab) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Merkel Cell Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed